Conferences - Results from #9900

SUO 2016: Panel on Surgical Management for Advanced Kidney Cancer: Controversies in Case Management - Session Highlights December 2, 2016

SUO 2016: Therapeutic Drug Trials and Targeted Therapies in Kidney Cancer: Q&A Session - Session Highlights December 2, 2016

SUO 2016: Targeted Therapies and Personalized Medicine in Kidney Cancer - Session Highlights December 2, 2016

SUO 2016: Therapeutic drug trials in kidney cancer in the immune-oncology era: Update on Current Status and Rationale for Combination Trials - Session Highlights December 2, 2016

SUO 2016: Evidence for colon cancer surveillance after resection and implications for urologic oncology - Session Highlights December 2, 2016

SUO 2016: Competing trade-offs for kidney cancer surveillance - Session Highlights December 2, 2016

SUO 2016: A systematic approach to discussing active surveillance to patients with low-risk prostate cancer - Session Highlights December 2, 2016

SUO 2016: Limiting overuse in asympomatic microhematuria evaluation, is there a safe way forward? - Session Highlights December 2, 2016

SUO 2016: Management of Residual Retroperitoneal Masses after Chemotherapy for Advanced Seminoma - Session Highlights December 1, 2016

SUO 2016: Anatomic Considerations for Nerve-Sparing RPLND - Session Highlights December 1, 2016

SUO 2016: Pitfalls in GCT Management: Urology - Session Highlights December 1, 2016

SUO 2016: Common pitfalls in the management of germ cell tumors: Medical Oncology - Session Highlights December 1, 2016

SUO 2016: SUO-CTC Session - Session Highlights December 1, 2016

SUO 2016: Challenging cases - Session Highlights December 1, 2016

SUO 2016: Role of salvage therapy in M0 CSPC - Session Highlights December 1, 2016

SUO 2016: Genomic classification of non-clear cell kidney cancer and implications for clinical management - Session Highlights December 1, 2016

SUO 2016: Novel Immune Approaches to Muscle Invasive Bladder Cancer - Session Highlights December 1, 2016

SUO 2016: Role of Definite Therapy in Oligometastatic Disease - Session Highlights December 1, 2016

SUO 2016: Novel Immune Approaches for High Risk Non-muscle Invasive Bladder Cancer - Session Highlights December 1, 2016

SUO 2016: Targeted approaches for T1 bladder cancer - Session Highlights December 1, 2016

Page 496 of 594